James Crowe Jr., MD, director of the Vanderbilt Vaccine Center at Vanderbilt University Medical Center, has received the Building the Foundation Award from Research!America, a national biomedical research advocacy organization, for his team’s role in developing human monoclonal antibodies and vaccine candidates against COVID-19.
The award, which was announced Oct. 6, recognizes individuals whose basic research discoveries have played a pivotal role in advancing public health. It is one of four awards for Outstanding Achievement in Public Health supported by Johnson & Johnson.
Crowe and other recipients of Research!America Advocacy Awards will be honored in March during the organization’s 27th annual Advocacy Awards program in Washington, D.C. The awards recognize individuals and organizations whose leadership efforts have advanced the nation’s commitment to medical, health and scientific research.
“We are proud to recognize all of our outstanding 2023 honorees,” said Mary Woolley, president and CEO of Research!America in a news release. “Each honoree, in different ways, has accelerated the pace of research progress, strengthened the research enterprise, and increased public and policymaker engagement in medical and health research.”
Read the full article: https://www.nashvillemedicalnews.com/article/5343/vanderbilts-crowe-receives-the-building-the-foundation-award-from-researchamerica